Bristol-Myers Squibb Co
BRM
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Contact
Route 206 and Province Line Road
Princeton
New JerseyNJ08543
USAT: +1 609 252-4621
E: timothy.power@bms.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
34,100
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,630.50 | 7.30 | -0.08% |
| CAC 40 | 7,779.72 | 8.38 | -0.11% |
| DAX 40 | 23,933.23 | 104.96 | -0.44% |
| Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
| FTSE 100 | 8,716.45 | 9.56 | -0.11% |
| HKSE | 23,242.71 | 330.67 | -1.40% |
| NASDAQ | 19,175.87 | 74.93 | 0.39% |
| Nikkei 225 | 37,869.03 | 563.95 | -1.47% |
| NZX 50 Index | 12,343.86 | 62.55 | 0.51% |
| S&P 500 | 5,912.17 | 23.62 | 0.40% |
| S&P/ASX 200 | 8,405.20 | 4.60 | -0.05% |
| SSE Composite Index | 3,353.07 | 10.38 | -0.31% |